TH-302 in Combination With Bevacizumab for Glioblastoma
Clinical trial NCT02342379 · COMPLETED
Trial details
- NCT number
- NCT02342379
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2019-01-04
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.